全膝关节置换术后常规全血细胞计数检查的临床影响
该回顾性研究纳入484例在止血带下接受初次全膝关节置换术的患者,分析术后全血细胞计数的效用与成本效益。结果显示,术前血红蛋白正常且使用氨甲环酸的患者,常规术后全血细胞计数不增加价值;术前贫血或未使用氨甲环酸的患者应进行术后全血细胞计数;若首次术后全血细胞计数未引发干预,则每日全血细胞计数不必要。
要点
- 术前贫血患者输血风险为无贫血者的5.2倍(95%CI 2.90-9.35,P<.001)。
- 未使用氨甲环酸的患者接受输血的可能性是使用者的2.75倍(95%CI 1.43-5.30,P<.001)。
- 未接受医疗干预的患者平均每人采集2.9次全血细胞计数,相关医院收费总计144,773.80美元(每人316.10美元)。
核心结论
- 在捆绑支付时代,确保全关节置换术后高质量、成本有效的患者护理至关重要。
- 对于术前血红蛋白正常且在止血带下全膝关节置换术中接受氨甲环酸的患者,常规术后全血细胞计数不增加价值。
- 术前贫血或未接受氨甲环酸的患者应进行术后全血细胞计数检查。
- 如果首次术后全血细胞计数未引发干预,则每日全血细胞计数不必要。
研究设计与样本
- 回顾性研究,在单家机构纳入484例在止血带下接受初次全膝关节置换术的患者。
- 收集术前和术后全血细胞计数数值,以及人口学数据、氨甲环酸使用情况和输血率。
- 对所有变量计算逻辑回归模型。
主要发现
- 25例患者(5.2%)在全膝关节置换术后需要输血。
- 需要输血的患者术前血红蛋白显著低于不需要输血的患者(11.47 vs 13.58 g/dL,P = .005)。
- 术前贫血患者输血风险为无贫血者的5.2倍(95%置信区间2.90-9.35,P < .001)。
- 未使用氨甲环酸的患者接受输血的可能性是使用者的2.75倍(95%置信区间1.43-5.30,P < .001)。
- 未接受医疗干预的患者平均每人采集2.9次全血细胞计数,相关医院收费总计144,773.80美元(每人316.10美元)。
临床怎么用
- 对于术前血红蛋白正常且在止血带下全膝关节置换术中接受氨甲环酸的患者,常规术后全血细胞计数不增加价值。
- 术前贫血或未接受氨甲环酸的患者应进行术后全血细胞计数检查。
- 如果首次术后全血细胞计数未引发干预,则每日全血细胞计数不必要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Routine laboratory studies are generally obtained following total knee arthroplasty (TKA), and often continued daily until discharge. This study aims to investigate the utility and cost-effectiveness of complete blood count (CBC) tests following TKA. METHODS: Retrospective review identified 484 patients who underwent primary TKA under a tourniquet at a single institution. Preoperative and postoperative CBC values were collected along with demographic data, use of tranexamic acid (TXA), and transfusion rates. Logistic regression models were calculated for all variables. RESULTS: Twenty-five patients required transfusion following TKA (5.2%). Patients requiring transfusion had significantly lower preoperative hemoglobin compared to patients who did not require transfusion (11.47 vs 13.58 g/dL, P = .005). Risk of transfusion was 5.2 times higher in patients with preoperative anemia (95% confidence interval 2.90-9.35, P < .001). Without TXA, patients were 2.75 times more likely to receive transfusion (95% confidence interval 1.43-5.30, P < .001). An average of 2.9 CBC tests were collected per patient who did not receive medical intervention, costing a total of $144,773.80 in associated hospital charges ($316.10 per patient). CONCLUSION: Ensuring quality, cost-effective patient care following total joint arthroplasty is essential in the era of bundled payments. Routine postoperative CBCs do not add value for patients with normal preoperative hemoglobin who receive TXA during TKA performed under tourniquet. Patients who are anemic preoperatively or do not receive TXA should obtain a postoperative CBC test. Daily CBCs are unnecessary if the first postoperative CBC does not prompt intervention.
引用
- Howell EP, Kildow BJ, Karas V, et al. Clinical Impact of Routine Complete Blood Counts Following Total Knee Arthroplasty. J Arthroplasty. 2019. PMID: 30948289. doi:10.1016/j.arth.2019.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。